Essa Pharma INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
EPIX
Essa Pharma INCESSA Pharma Inc. has halted its clinical trials for masofaniten (EPI-7386) and is exploring strategic options to maximize shareholder value.